VJVirtual

CAR-HEMATOTOX: predictive model of hematotoxicity after CAR T-cell treatment 4:24
CAR-HEMATOTOX: predictive model of hematotoxicity after CAR T-cell treatment
Kai Rejeski • 1 Feb 2021
Update on ARI-0001 for patients with CD19+ R/R malignancies 2:47
Update on ARI-0001 for patients with CD19+ R/R malignancies
Manel Juan Otero • 25 Jan 2021
Regulatory considerations for CAR-T academic trials 1:45
Regulatory considerations for CAR-T academic trials
Manel Juan Otero • 25 Jan 2021
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease 3:11
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado • 3 Feb 2021
Universal “off-the-shelf” CAR T-cells from iPSCs 4:58
Universal “off-the-shelf” CAR T-cells from iPSCs
Alexandros Nianias • 6 Feb 2021
CAR-T vs. BiTEs in B-cell malignancies 6:09
CAR-T vs. BiTEs in B-cell malignancies
Marion Subklewe • 11 Feb 2021
CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias 3:50
CAR T-cell toxicity: CRS, ICANS and prolonged cytopenias
Marion Subklewe • 11 Feb 2021
CAR-Treg therapy for systemic lupus erythematosus 2:15
CAR-Treg therapy for systemic lupus erythematosus
Matteo Doglio • 28 Jan 2021
An overview of the CAR T-cell therapy story 3:39
An overview of the CAR T-cell therapy story
Mohamad Mohty • 26 Jan 2021
Practical aspects of CAR T-cell therapy 4:14
Practical aspects of CAR T-cell therapy
Ulrich Jäger • 9 Feb 2021
The challenges of CAR T-cell therapy for pediatric B-ALL 4:18
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian • 4 Feb 2021
CAR-T therapy: treatment burden and costs 1:15
CAR-T therapy: treatment burden and costs
Erik Aerts • 4 Feb 2021
The future of CAR T-cell therapy in lymphoma 2:15
The future of CAR T-cell therapy in lymphoma
Anna Sureda • 9 Feb 2021
ARI-0001 in CD19+ malignancies: next steps 1:12
ARI-0001 in CD19+ malignancies: next steps
Valentín Ortiz-Maldonado • 3 Feb 2021
Updates on CAR T-cell therapy in B-cell malignancies 2:16
Updates on CAR T-cell therapy in B-cell malignancies
Ulrich Jäger • 9 Feb 2021
Liso-cel for R/R large B-cell lymphoma 1:44
Liso-cel for R/R large B-cell lymphoma
Ulrich Jäger • 9 Feb 2021
The content of VJRegenMed is intended for healthcare professionals